Barriers of General Practitioner Regarding Helicobacter Pylori.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-15

Study Completion Date

2026-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the knowledge, attitudes, and clinical practices of general practitioners regarding the diagnosis and treatment of Helicobacter pylori infection. The study also seeks to identify the main barriers that prevent proper management of the condition. The central hypothesis is that gaps in knowledge and challenges in clinical practice contribute to variations in how general practitioners diagnose and treat H. pylori infection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study explores the knowledge, attitudes, and practices of general practitioners regarding the diagnosis and treatment of Helicobacter pylori infection. It also examines the barriers that may affect appropriate clinical decision-making in managing this common gastrointestinal condition. By assessing physicians' understanding of recommended diagnostic techniques, treatment regimens, and follow-up strategies, the study aims to identify areas where education or system-level improvements may be needed.

The study hypothesizes that insufficient knowledge of current guidelines, limited access to diagnostic tests, and patient-related or system-related barriers contribute to inconsistent management of H. pylori infection among general practitioners. The findings may help inform future training programs and improve patient care outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

H.Pylori Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Demographic , knowledge , Practices , attitude and barriers

Section A: demographic data (age, gender, years of experience, workplace) Section B: knowledge (transmission, symptoms, diagnostic methods,. treatment guidelines) Section C: attitude (perceived importance, confidence in diagnosis/treatment) Section D: practice (frequency of testing, treatment regimen used). Section E: barriers (e.g., Lack of resources, guidelines, time constraints, patient adherence)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Licensed general practitioners actively working primary health care centers, outpatients clinics and general hospitals in Upper Egypt( Assuit, Minya, Sohag, Qena, luxor and Aswan).

Exclusion Criteria

* Specialists in gastroenterology.

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohanad Abd_Elaleem Sayed Amer

Resident at tropical department.

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mohanad Abd_Elaleem Sayed

Role: CONTACT

[email protected]

01122085058

Mohamed Abdel-Sabour Mohamed Mekky Abdel-Sabour Mohamed Mekky